683 Capital Management »

Arcturus Therapeutics Hldg I shares owned by 683 Capital Management

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $147k 24k 6.13
2020-09-30 $723k 17k 42.90
2020-06-30 $788k 17k 46.75
2020-03-31 $229k 17k 13.59
2019-12-31 $177k 16k 10.86

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
ARK Investment Management
Balyasny Asset Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
State Street Corporation
Jane Street
Dimensional Fund Advisors
Acadian Asset Management
Empire Life Investments
Goldman Sachs Group
Jacobs Levy Equity Management

View all funds holding Arcturus Therapeutics Hldg I